Summary
BEOnChip S.L. is a leading Spanish company focused on the field of Micro-biotechnology.
We have fully engineered microchips that recapitulate the microarchitecture and functions of living human organs. These microchips, called “organs-on-chips”, can be defined as micro-sized artificial organs and can revolutionize drug development. Now, in the B-On-Chip project we seek bringing to the market the first compact, fully automated and easy-to-use device to link multiple organs-on-chip, enabling the so called body-on-chip experiments. The use of B-On-Chip by the Pharma industry in new drug discovery, has the potential to slash the use of laboratory animals in drug testing. Furthermore, the more realistic data offered by B-On-Chip will accelerate drug development and allow researchers to carry out experiments too risky for human volunteers. Moreover, by linking different “organ-on-chips” together, it will be possible to study how reactions in one organ affect another. B-On-Chip will offer the most accurate data on new drug efficiency, security, toxicity in a fast, automatic and reliable way, with the breakthrough advantage of being able to offer these results in in vitro experiments.
We have fully engineered microchips that recapitulate the microarchitecture and functions of living human organs. These microchips, called “organs-on-chips”, can be defined as micro-sized artificial organs and can revolutionize drug development. Now, in the B-On-Chip project we seek bringing to the market the first compact, fully automated and easy-to-use device to link multiple organs-on-chip, enabling the so called body-on-chip experiments. The use of B-On-Chip by the Pharma industry in new drug discovery, has the potential to slash the use of laboratory animals in drug testing. Furthermore, the more realistic data offered by B-On-Chip will accelerate drug development and allow researchers to carry out experiments too risky for human volunteers. Moreover, by linking different “organ-on-chips” together, it will be possible to study how reactions in one organ affect another. B-On-Chip will offer the most accurate data on new drug efficiency, security, toxicity in a fast, automatic and reliable way, with the breakthrough advantage of being able to offer these results in in vitro experiments.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/762315 |
| Start date: | 01-01-2017 |
| End date: | 31-05-2017 |
| Total budget - Public funding: | 71 429,00 Euro - 50 000,00 Euro |
Cordis data
Original description
BEOnChip S.L. is a leading Spanish company focused on the field of Micro-biotechnology.We have fully engineered microchips that recapitulate the microarchitecture and functions of living human organs. These microchips, called “organs-on-chips”, can be defined as micro-sized artificial organs and can revolutionize drug development. Now, in the B-On-Chip project we seek bringing to the market the first compact, fully automated and easy-to-use device to link multiple organs-on-chip, enabling the so called body-on-chip experiments. The use of B-On-Chip by the Pharma industry in new drug discovery, has the potential to slash the use of laboratory animals in drug testing. Furthermore, the more realistic data offered by B-On-Chip will accelerate drug development and allow researchers to carry out experiments too risky for human volunteers. Moreover, by linking different “organ-on-chips” together, it will be possible to study how reactions in one organ affect another. B-On-Chip will offer the most accurate data on new drug efficiency, security, toxicity in a fast, automatic and reliable way, with the breakthrough advantage of being able to offer these results in in vitro experiments.
Status
CLOSEDCall topic
SMEInst-05-2016-2017Update Date
26-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
